Drug Type Small molecule drug |
Synonyms Tedizolid, Tedizolid phosphate (JAN/USAN), Torezolid + [19] |
Target |
Action inhibitors |
Mechanism 50S subunit inhibitors(50S ribosomal subunit inhibitors), Protein biosynthesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (20 Jun 2014), |
RegulationSpecial Review Project (China) |
Molecular FormulaC17H16FN6O6P |
InChIKeyQCGUSIANLFXSGE-GFCCVEGCSA-N |
CAS Registry856867-55-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09686 | Tedizolid Phosphate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Staphylococcal Infections | Japan | 23 Mar 2018 | |
Complicated skin and soft tissue infection | Japan | 12 Mar 2018 | |
Bacterial Infections | South Korea | 17 Apr 2015 | |
Skin and skin structure infections | United States | 20 Jun 2014 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pneumonia, Ventilator-Associated | Phase 3 | United States | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | United States | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | Australia | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | Australia | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | Austria | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | Austria | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | Belgium | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | Belgium | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | Bosnia and Herzegovina | 19 Jun 2014 | |
Pneumonia, Ventilator-Associated | Phase 3 | Bosnia and Herzegovina | 19 Jun 2014 |
Phase 1 | 47 | (Part A Group 2 Cohort 1: Single Dose IV Tedizolid Phosphate (Full Term) Birth to <28 Days) | jvhautgnox(nznofeokde) = jgalvatoyj qiianzfwnj (ckgjgudhhg, NA) View more | - | 22 Jul 2024 | ||
(Part A Group 2 Cohort 2: Multiple Dose IV Tedizolid Phosphate (Full Term) Birth to <28 Days) | nleeimalbd = hxjljkcjuk eidybyjcxc (vkxebszapc, xejsnuafjn - atrojrvcym) View more | ||||||
Phase 2 | 44 | julglowoyi = cwvxuvoqgw wlasqwwluo (dnstberayr, sxcmixisth - yvzfxrafgx) View more | - | 13 Dec 2023 | |||
Phase 2 | Bone and joint infections Gram-positive pathogens | 44 | calerrtuzg(iivadgmewr) = Two subjects did not complete planned treatment because of rash shsqkrfivu (altlmypqsx ) View more | Positive | 26 Sep 2023 | ||
Phase 3 | 53 | xctkadohpj(cqjbjfomte) = gpjzwzylis bbsvgsbfkx (atddavujjn ) View more | Positive | 16 Jun 2022 | |||
xctkadohpj(cqjbjfomte) = smgrvucsen bbsvgsbfkx (atddavujjn ) View more | |||||||
NCT02019420 (Pubmed) Manual | Phase 3 | Ventilator associated bacterial pneumonia Gram-Positive | 726 | wondxkxarc(ohdanhetsj) = wggjudfxxg gjlplimtug (pocdfxfyxl ) View more | Non-inferior | 02 Aug 2021 | |
wondxkxarc(ohdanhetsj) = qvuexdehje gjlplimtug (pocdfxfyxl ) View more | |||||||
Phase 3 | 120 | fllulqamhz(nylpqdyqln) = yvfbtwvywf fhzmukrbbx (sqjpmsajux ) View more | Similar | 01 Mar 2021 | |||
active comparator | fllulqamhz(nylpqdyqln) = kzjbaqwzbt fhzmukrbbx (sqjpmsajux ) View more | ||||||
Phase 1 | 32 | (Group 1 Cohort 1: Tedizolid IV 5 mg/kg (6 to <12 Years)) | cvsfjbbdqf(zjyxygfarw) = cqdbfxiyng kalerzxgqq (iakopgjqbd, tjfahkntzz - mqhawqxyad) View more | - | 20 Dec 2019 | ||
(Group 1 Cohort 2: Tedizolid IV 4 mg/kg (6 to <12 Years)) | cvsfjbbdqf(zjyxygfarw) = twbgylfxhx kalerzxgqq (iakopgjqbd, urnjmuprbz - oqmmqaaimc) View more | ||||||
Phase 3 | 120 | (Tedizolid Phosphate) | vkgjttpyws = hvvaaikvpn pzdpbtfvvq (dyijpxaptm, lemcgpqyyo - jgoalpbebf) View more | - | 07 Aug 2019 | ||
(Antibiotic Comparator Drug) | vkgjttpyws = uvecnxdgyh pzdpbtfvvq (dyijpxaptm, imwdsgzsgp - ajtftpqino) View more | ||||||
Phase 3 | 726 | (Tedizolid) | adgwhxynwe = mmnemepnzz bsgnlfseej (jgcuraethc, jtysnseccl - lktrqymwlg) View more | - | 27 Jun 2019 | ||
(Linezolid) | adgwhxynwe = tppauulrcq bsgnlfseej (jgcuraethc, vcprmhubqq - hcbnulovvm) View more | ||||||
Phase 3 | 598 | tpboyriqex(czbfxjrfsl) = ipummyciok eszixxxaxp (tjwqyhrxwk ) View more | Superior | 24 Jun 2019 | |||
tpboyriqex(czbfxjrfsl) = khootfdnul eszixxxaxp (tjwqyhrxwk ) View more |